Related Experiment Video
Updated: Jan 24, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Increased plasma microfibrillar-associated protein 4 is associated with atrial fibrillation and more advanced left
Xianlin Zhang1,2, Hailing Li1, Wenxin Kou1
1Department of Cardiology, Shanghai Tenth People's Hospital of Nanjing Medical University; Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Introduction:
This study aimed to evaluate the relationship of plasma microfibrillar-associated protein 4 (MFAP4) to atrial fibrillation (AF) and atrial structural remodelling.
Material And Methods:
Plasma MFAP4 levels were measured in 92 patients with AF (61 paroxysmal AF (PAF) patients and 31 persistent AF (PersAF) patients) and 71 control subjects without AF. Linear and logistic multivariate regression analyses were performed to determine the potential value of MFAP4 for predicting the incidence of AF and left atrial size. Then, plasma and atrial protein levels of MFAP4 and its association with atrial fibrosis ratio were analysed in an atrial-specific fibrosis rat model.
Results:
There were significant differences in MFAP4 levels based on clinical group, with a gradient from control (1.71 ±0.53 ng/ml) to PAF (1.98 ±0.53 ng/ml) to PersAF (2.09 ±0.76 ng/ml) (p < 0.01). With multivariate analyses, plasma MFAP4 was found to be an independent determinant of left atrial diameter in AF patients. In atrial fibrosis rats, both plasma MFAP4 and atrial MFAP4 protein levels increased in atrial fibrosis rats and positively correlated with atrial fibrosis severity.
Conclusions:
Plasma MFAP4 was increased in patients with AF and was highest in those with PersAF; both plasma MFAP4 and atrial MFAP4 protein expression were directly associated with the extent of LA structural remodelling.
Insights
Plasma microfibrillar-associated protein 4 (MFAP4) is elevated in atrial fibrillation (AF) patients, particularly persistent AF. Higher MFAP4 levels correlate with left atrial enlargement and fibrosis, suggesting its role in AF progression.
Area of Science:
- Cardiology
- Biochemistry
- Medical Research
Background:
- Atrial fibrillation (AF) is a common arrhythmia associated with structural changes in the atria.
- Microfibrillar-associated protein 4 (MFAP4) is a protein found in extracellular matrix, but its role in AF is not well understood.
Purpose of the Study:
- To investigate the association between plasma microfibrillar-associated protein 4 (MFAP4) levels and atrial fibrillation (AF).
- To evaluate the relationship of MFAP4 to atrial structural remodeling, including left atrial size and fibrosis.
Main Methods:
- Plasma MFAP4 levels were measured in 92 AF patients (paroxysmal AF and persistent AF) and 71 controls.
- Multivariate regression analyses were used to assess MFAP4's predictive value for AF incidence and left atrial size.
- MFAP4 levels and fibrosis were analyzed in an atrial-specific fibrosis rat model.
Main Results:
- Plasma MFAP4 levels showed a gradient, increasing from controls to paroxysmal AF to persistent AF patients (p < 0.01).
- Plasma MFAP4 was an independent determinant of left atrial diameter in AF patients.
- In rats, both plasma and atrial MFAP4 levels increased with atrial fibrosis and correlated positively with its severity.
Conclusions:
- Plasma MFAP4 is elevated in AF patients, with the highest levels in persistent AF.
- Both plasma and atrial MFAP4 protein expression are directly associated with the extent of left atrial structural remodeling and fibrosis.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Protein Buffers in Blood Plasma and Cells
Certain amino acids can exist in a zwitterion state at a...
Drug Distribution: Plasma Protein Binding

